Antiemetic guidelines

Creating a more practical treatment approach

Jim M. Koeller, Matti S. Aapro, Richard J. Gralla, Steven M. Grunberg, Paul J. Hesketh, Mark G. Kris, Rebecca A. Clark-Snow

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Antiemetic guidelines from a variety of professional organizations have been available for several years. It is unclear just how often these guidelines have been used, however; data indicate that some practitioners still do not treat their patients according to the recommendations. Some of those involved in the creation of the original guidelines convened to try to create a simpler, more practical approach to the use of antiemetics in preventing chemotherapy-induced nausea and vomiting. The group's intention was to clarify available guidelines and produce a practical document, based on evidence, that could be used in everyday practice. The group created four consensus statements that would serve as a basis for their recommendations. One primary strategy used was to have chemotherapy-induced nausea and vomiting viewed as a single process that can occur throughout a treatment cycle, and not so much as an acute and a delayed process, as is usual in clinical trials. Patients' management should be considered over a 4- to 5-day period, rather than primarily dealing with the day of treatment only. The group created three tables: emetic risk of chemotherapy; treatment options based on emetic category; and antiemetic dosing recommendations. Use of these tables should make appropriate antiemetic selection more straightforward and easier for the practitioner in an everyday setting. Although this document alone may not solve all the challenges with appropriate antiemetic management, it will hopefully prove to be a step in the right direction.

Original languageEnglish (US)
Pages (from-to)519-522
Number of pages4
JournalSupportive Care in Cancer
Volume10
Issue number7
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Antiemetics
Guidelines
Emetics
Drug Therapy
Nausea
Vomiting
Therapeutics
Consensus
Clinical Trials

Keywords

  • Antiemetic treatment guidelines
  • Appropriate use
  • Chemotherapy-induced nausea and vomiting

ASJC Scopus subject areas

  • Oncology
  • Nursing(all)

Cite this

Koeller, J. M., Aapro, M. S., Gralla, R. J., Grunberg, S. M., Hesketh, P. J., Kris, M. G., & Clark-Snow, R. A. (2002). Antiemetic guidelines: Creating a more practical treatment approach. Supportive Care in Cancer, 10(7), 519-522. https://doi.org/10.1007/s00520-001-0335-y

Antiemetic guidelines : Creating a more practical treatment approach. / Koeller, Jim M.; Aapro, Matti S.; Gralla, Richard J.; Grunberg, Steven M.; Hesketh, Paul J.; Kris, Mark G.; Clark-Snow, Rebecca A.

In: Supportive Care in Cancer, Vol. 10, No. 7, 2002, p. 519-522.

Research output: Contribution to journalArticle

Koeller, JM, Aapro, MS, Gralla, RJ, Grunberg, SM, Hesketh, PJ, Kris, MG & Clark-Snow, RA 2002, 'Antiemetic guidelines: Creating a more practical treatment approach', Supportive Care in Cancer, vol. 10, no. 7, pp. 519-522. https://doi.org/10.1007/s00520-001-0335-y
Koeller, Jim M. ; Aapro, Matti S. ; Gralla, Richard J. ; Grunberg, Steven M. ; Hesketh, Paul J. ; Kris, Mark G. ; Clark-Snow, Rebecca A. / Antiemetic guidelines : Creating a more practical treatment approach. In: Supportive Care in Cancer. 2002 ; Vol. 10, No. 7. pp. 519-522.
@article{b3a857672f7949528fdc600f44ccb2d5,
title = "Antiemetic guidelines: Creating a more practical treatment approach",
abstract = "Antiemetic guidelines from a variety of professional organizations have been available for several years. It is unclear just how often these guidelines have been used, however; data indicate that some practitioners still do not treat their patients according to the recommendations. Some of those involved in the creation of the original guidelines convened to try to create a simpler, more practical approach to the use of antiemetics in preventing chemotherapy-induced nausea and vomiting. The group's intention was to clarify available guidelines and produce a practical document, based on evidence, that could be used in everyday practice. The group created four consensus statements that would serve as a basis for their recommendations. One primary strategy used was to have chemotherapy-induced nausea and vomiting viewed as a single process that can occur throughout a treatment cycle, and not so much as an acute and a delayed process, as is usual in clinical trials. Patients' management should be considered over a 4- to 5-day period, rather than primarily dealing with the day of treatment only. The group created three tables: emetic risk of chemotherapy; treatment options based on emetic category; and antiemetic dosing recommendations. Use of these tables should make appropriate antiemetic selection more straightforward and easier for the practitioner in an everyday setting. Although this document alone may not solve all the challenges with appropriate antiemetic management, it will hopefully prove to be a step in the right direction.",
keywords = "Antiemetic treatment guidelines, Appropriate use, Chemotherapy-induced nausea and vomiting",
author = "Koeller, {Jim M.} and Aapro, {Matti S.} and Gralla, {Richard J.} and Grunberg, {Steven M.} and Hesketh, {Paul J.} and Kris, {Mark G.} and Clark-Snow, {Rebecca A.}",
year = "2002",
doi = "10.1007/s00520-001-0335-y",
language = "English (US)",
volume = "10",
pages = "519--522",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "7",

}

TY - JOUR

T1 - Antiemetic guidelines

T2 - Creating a more practical treatment approach

AU - Koeller, Jim M.

AU - Aapro, Matti S.

AU - Gralla, Richard J.

AU - Grunberg, Steven M.

AU - Hesketh, Paul J.

AU - Kris, Mark G.

AU - Clark-Snow, Rebecca A.

PY - 2002

Y1 - 2002

N2 - Antiemetic guidelines from a variety of professional organizations have been available for several years. It is unclear just how often these guidelines have been used, however; data indicate that some practitioners still do not treat their patients according to the recommendations. Some of those involved in the creation of the original guidelines convened to try to create a simpler, more practical approach to the use of antiemetics in preventing chemotherapy-induced nausea and vomiting. The group's intention was to clarify available guidelines and produce a practical document, based on evidence, that could be used in everyday practice. The group created four consensus statements that would serve as a basis for their recommendations. One primary strategy used was to have chemotherapy-induced nausea and vomiting viewed as a single process that can occur throughout a treatment cycle, and not so much as an acute and a delayed process, as is usual in clinical trials. Patients' management should be considered over a 4- to 5-day period, rather than primarily dealing with the day of treatment only. The group created three tables: emetic risk of chemotherapy; treatment options based on emetic category; and antiemetic dosing recommendations. Use of these tables should make appropriate antiemetic selection more straightforward and easier for the practitioner in an everyday setting. Although this document alone may not solve all the challenges with appropriate antiemetic management, it will hopefully prove to be a step in the right direction.

AB - Antiemetic guidelines from a variety of professional organizations have been available for several years. It is unclear just how often these guidelines have been used, however; data indicate that some practitioners still do not treat their patients according to the recommendations. Some of those involved in the creation of the original guidelines convened to try to create a simpler, more practical approach to the use of antiemetics in preventing chemotherapy-induced nausea and vomiting. The group's intention was to clarify available guidelines and produce a practical document, based on evidence, that could be used in everyday practice. The group created four consensus statements that would serve as a basis for their recommendations. One primary strategy used was to have chemotherapy-induced nausea and vomiting viewed as a single process that can occur throughout a treatment cycle, and not so much as an acute and a delayed process, as is usual in clinical trials. Patients' management should be considered over a 4- to 5-day period, rather than primarily dealing with the day of treatment only. The group created three tables: emetic risk of chemotherapy; treatment options based on emetic category; and antiemetic dosing recommendations. Use of these tables should make appropriate antiemetic selection more straightforward and easier for the practitioner in an everyday setting. Although this document alone may not solve all the challenges with appropriate antiemetic management, it will hopefully prove to be a step in the right direction.

KW - Antiemetic treatment guidelines

KW - Appropriate use

KW - Chemotherapy-induced nausea and vomiting

UR - http://www.scopus.com/inward/record.url?scp=0036933329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036933329&partnerID=8YFLogxK

U2 - 10.1007/s00520-001-0335-y

DO - 10.1007/s00520-001-0335-y

M3 - Article

VL - 10

SP - 519

EP - 522

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 7

ER -